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Abstract
 
The roles of the NADPH phagocyte oxidase (phox) and inducible nitric oxide synthase
(iNOS) in host resistance to virulent 
 
Salmonella typhimurium
 
 were investigated in gp91
 
phox
 
2
 
/
 
2
 
,
 
iNOS
 
2
 
/
 
2
 
,
 
 
 
and congenic wild-type mice. Although both gp91
 
phox
 
2
 
/
 
2
 
 and 
 
iNOS
 
2
 
/
 
2
 
 
 
mice
demonstrated increased susceptibility to infection with 
 
S
 
.
 
 typhimurium
 
 compared with wild-
type mice, the kinetics of bacterial replication were dramatically different in the gp91
 
phox
 
2
 
/
 
2
 
and 
 
iNOS
 
2
 
/
 
2
 
 mouse strains. Greater bacterial numbers were present in the spleens and livers of
gp91
 
phox
 
2
 
/
 
2
 
 mice compared with C57BL/6 controls as early as day 1 of infection, and all of
the gp91
 
phox
 
2
 
/
 
2
 
 mice succumbed to infection within 5 d. In contrast, an increased bacterial
burden was detected within reticuloendothelial organs of 
 
iNOS
 
2
 
/
 
2
 
 mice only beyond the first
week of infection. Influx of inflammatory CD11b
 
1 
 
cells, granuloma formation, and serum in-
terferon 
 
g
 
 levels were unimpaired in 
 
iNOS
 
2
 
/
 
2
 
 
 
mice, but the iNOS-deficient granulomas were
unable to limit bacterial replication. The NADPH phagocye oxidase and iNOS are both re-
quired for host resistance to wild-type 
 
Salmonella, 
 
but appear to operate principally at different
stages of infection.
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Introduction
 
Salmonella
 
 infections afflicting animals and humans pose a
serious medical and veterinary problem worldwide. Despite
considerable progress in understanding the genetic deter-
minants of 
 
Salmonella 
 
virulence, rational vaccine design is
still hampered by an inadequate understanding of the essen-
tial elements of host resistance to 
 
Salmonella
 
. Much of the
current knowledge of mechanisms of natural resistance and
acquired immunity in salmonellosis has been generated in
the mouse typhoid model (1–3), in which polymorphonu-
clear and mononuclear phagocytes play a critical role by
limiting initial bacterial replication (4–10). In immuno-
competent mice, bacterial growth in the reticulendothelial
system is suppressed by the end of the first week of infec-
tion, resulting in a plateau phase (11). This requires an in-
flux of bone marrow–derived mononuclear cells and coin-
cides with the onset of hepatosplenomegaly and granuloma
formation, but does not require functional CD4
 
1
 
 or CD8
 
1
 
T cells (11). Soluble factors including TNF-
 
a
 
, IFN-
 
g
 
, IL-
12, and IL-18 are essential for the suppression of bacterial
growth during sublethal 
 
Salmonella
 
 infections (9, 12–22),
and are specifically required for granuloma formation (9,
12, 17) and macrophage activation (14, 20). Secondary in-
fection in immunized mice additionally involves 
 
Salmo-
nella
 
-immune CD4
 
1
 
 and CD8
 
1
 
 T cells and 
 
Salmonella
 
-spe-
cific antibodies (3, 17).
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Roles of phox and iNOS in Resistance to 
 
Salmonella
 
The mechanisms by which phagocytes inhibit or kill vir-
ulent salmonellae are incompletely characterized, but the
NADPH phagocyte oxidase has been strongly implicated
(23, 24). The NADPH phagocyte oxidase catalyzes the
production of superoxide (O
 
2
 
?
 
2
 
) that can be metabolized
to a variety of toxic reactive oxygen species (ROS).
 
1
 
 Pa-
tients deficient in the NADPH phagocyte oxidase are sus-
ceptible to recurrent microbial infections, including salmo-
nellosis
 
 
 
(25), in a clinical condition known as chronic
granulomatous disease (CGD; for a review, see reference
26). The gp91
 
phox
 
 gene encoding an essential component
of the NADPH phagocyte oxidase has been targeted in
mice, resulting in the elimination of oxidative burst activity
in neutrophils and macrophages and an increased suscepti-
bility to microorganisms including 
 
Salmonella typhimurium
 
(24), 
 
Aspergillus fumigatus, Staphylococcus aureus 
 
(26),
 
 
 
and
 
Mycobacterium tuberculosis 
 
(27).
The role of the inducible nitric oxide (NO) synthase
(iNOS) in the ability of macrophages to inhibit or kill 
 
Sal-
monella
 
 has been somewhat less clear (28, 29). Dimeric
iNOS catalyzes the conversion of 
 
l
 
-arginine to 
 
l
 
-citrulline
with the production of NO
 
?
 
, which can be further metab-
olized to a variety of congeners (reactive nitrogen species
[RNS]) with antimicrobial activity (30). Activated mac-
rophages display increased expression of iNOS and elevated
production of NO
 
?
 
 derivatives (for a review, see refer-
ence 30). The role of NO
 
?
 
 derivatives in host resistance to
microbes has been documented in vitro and in vivo in a
large number of infection models (for a review, see refer-
ence 31).
Generation of O
 
2
 
?
 
2
 
 and NO
 
?
 
 derivatives in response to
 
Salmonella
 
 infection has been documented both in vivo
(20, 32) and in vitro (24, 33–35). The activity of iNOS is
positively regulated by several cytokines (IL-12, IFN-
 
g
 
,
TNF-
 
a
 
) known to be essential for host resistance to 
 
Salmo-
nella 
 
(12, 20, 30). Evidence obtained using metabolic in-
hibitors and immunodeficient knockout mice suggests that
oxygen radicals mediate resistance to 
 
Salmonella
 
 in mice and
are required for maximal bacterial killing by macrophages
(24, 29). Furthermore, data obtained using NO synthase
(NOS) inhibitors L-NMMA or aminoguanidine support a
role for NO
 
?
 
 derivatives in host resistance to 
 
Salmonella
 
 (32,
33, 36). However, some evidence from in vitro models has
suggested that the respiratory burst oxidase, but not iNOS,
is essential to kill virulent 
 
Salmonella
 
, whereas both ROS
and RNS are involved in the killing of some mutant 
 
Salmo-
nella 
 
strains (24, 28, 29). Moreover, observations using the
NOS-inhibitor aminoguanidine have suggested that iNOS
may regulate infiltration of inflammatory cells in the tissues,
rather than exert direct antimicrobial activity against 
 
Salmo-
nella
 
 (36).
Many of the published studies examining phox-depen-
dent and iNOS-dependent host defenses in salmonellosis
have used attenuated bacterial strains and innately suscepti-
 
ble mice, making it somewhat difficult to ascertain the role
of these defenses in infections with virulent 
 
Salmonella 
 
(29,
32, 33, 36). The goal of this study was to clarify the roles of
the NADPH phagocyte oxidase and iNOS in limiting bac-
terial replication during experimental infection with viru-
lent 
 
S. typhimurium
 
, using gp91
 
phox
 
2
 
/
 
2
 
 mice in a 
 
Salmo-
nella
 
-susceptible C57BL/6 (
 
Nramp1
 
s
 
) genetic background,
and 
 
iNOS
 
2
 
/
 
2
 
 mice in both C57BL/6- (
 
Nramp1
 
s
 
) and 
 
Sal-
monella
 
-resistant 129Sv (
 
Nramp1
 
r
 
) genetic backgrounds.
Sublethal inocula of wild-type 
 
Salmonella
 
 were adminis-
tered to facilitate the detection of phox-dependent and
iNOS-dependent antimicrobial actions.
 
Materials and Methods
 
Animals.
 
C57BL/6 mice (
 
Nramp1
 
s
 
) and 129Sv mice (
 
Nramp1
 
r
 
)
were purchased from Harlan Olac, Ltd. Mice homozygous for a
targeted mutation in the gp91 subunit of the NADPH oxidase
(gp91
 
phox
 
2
 
/
 
2
 
) on a C57BL/6 background (26) were bred at the
University of Colorado School of Medicine Center for Labora-
tory Animal Care. Mice homozygous for a targeted mutation in
the iNOS gene (
 
iNOS
 
2
 
/
 
2
 
 [37, 38]) on a C57BL/6 or 129Sv
background were bred at either B
 
a
 
K Universal, Ltd. or the Im-
perial College animal unit.
Bacteria. S. typhimurium M525P, a variant of S. typhimurium
M525 (18), is a wild-type strain of intermediate virulence. S. ty-
phimurium C5 is a highly virulent strain (6). For intravenous inoc-
ulation, bacteria were grown at 378C as stationary overnight cul-
tures in Luria-Bertani (LB) broth (Difco). Aliquots were snap
frozen and stored in liquid nitrogen. The inoculum was diluted
in PBS and injected in a lateral tail vein. The number of viable
bacteria in each inoculum was checked by dilution and pour plat-
ing onto LB agar plates.
Bacterial Enumeration in Organ Homogenates. Mice were killed
by cervical dislocation. Spleens and livers were aseptically re-
moved and homogenized in a Colworth Stomacher in 10 ml of
cold distilled water (11). Viable counts were determined using
pour plates of LB agar.
LD50 Determinations. Groups of mice were injected intrave-
nously with 10-fold decreasing doses of S. typhimurium M525P or
S. typhimurium C5. Parallel groups of age-matched uninfected
mice were observed in parallel during each experiment. Mortality
was scored over a 30-d period. LD50 values were calculated ac-
cording to the method of Reed and Muench (39).
IFN-g ELISA. Mice were bled from a lateral tail vein. Sera
were collected and stored at 2708C. IFN-g was measured by
capture ELISA using antibody pairs and cytokine standards pur-
chased from BD PharMingen.
For IFN-g determinations, 96 multiwell ELISA plates (Maxi-
Sorp Immuno Plate; Nunc) were coated overnight at 48C with
50 ml/well of a rat anti–mouse IFN-g IgG1 monoclonal capture
antibody (clone R4-6A2) in 0.1 M NaHCO3 buffer, pH 9.5 at 2
mg/ml. After blocking with PBS supplemented with 10% FCS at
378C for 1 h, twofold serum dilutions were loaded in 50 ml in
triplicate, and the plates were incubated at 378C for 2 h. Serial
twofold dilutions of rIFN-g ranging from 20 ng/ml to 40 pg/ml
were included as standards. Biotinylated rat anti–mouse IFN-g
IgG1 mAb (clone XMG1.2; 100 ml/well) at 1 mg/ml in PBS
supplemented with 10% FCS was added for 1 h at 378C, after
which 100 ml/well of peroxidase-labeled streptavidin at 2.5 mg/
ml (Sigma-Aldrich) in PBS supplemented with 10% FCS was
added for 45 min at room temperature. Ortho-phenylenediamine
1Abbreviations used in this paper: iNOS, inducible nitric oxide synthase; LB,
Luria-Bertani; NO, nitric oxide; NOS, nitric oxide synthase; RNS, reac-
tive nitrogen species; ROS, reactive oxygen species. 239 Mastroeni et al.
(OPD; 1 mg/ml in 0.2 M Na2HPO4, 0.1 M citrate buffer) in the
presence of H2O2 was used to develop the plates. The reaction
was stopped by adding 15 ml/well of 3 M H2SO4. OD was read
at 490 nm. IFN-g values (ng/ml) were determined by compari-
son with the standard curve. 80 pg/ml was considered to be the
lower limit of sensitivity of this IFN-g ELISA test.
Histology. 8-mm thick sections were prepared from tissues
fixed by immersion in 10% formalinized saline, and were stained
with hematoxylin and eosin. The number of focal lesions in sev-
eral nonserial liver sections was counted at low-power magnifica-
tion (310) using a Nikon Labophot 2 microscope. The results
were obtained by counting 15 fields per organ.
Staining for Flow Cytometry Analysis. Single cell suspensions
prepared from mouse spleens were washed once in Ca21- and
Mg21-free Dulbecco’s PBS containing 2 mM EDTA (Sigma-
Aldrich) by centrifugation at 300 g and incubation in Gey’s solution
to lyse the red cells. White cells were washed twice more before
being resuspended at a concentration of 107/ml in PBS contain-
ing 1% FCS, 0.1% NaN3, and 2 mM EDTA. All further steps
were performed on ice. Antibodies for flow cytometry were pur-
chased from BD PharMingen, with the exception of the anti–
I-Ab MHC class II FITC-conjugated antibody, which was obtained
from Caltag Laboratories. FcgIII/II receptors were blocked by
incubating cells with the rat anti–mouse CD16/CD32 (IgG2b;
clone 2.4G2) mAb for 10 min. The following antibodies were
used: FITC–anti-CD4 (IgG2a; clone RM4-4), FITC–anti-CD8
(IgG2a; clone 53-6.7), PE–anti-CD11b (IgG2b; clone M1/70),
FITC–anti-B220 (IgG2a; clone RA3-6B2), PE–anti-CD25
(IgG1; clone PC61), and FITC–anti–I-Ab MHC class II (IgM;
clone 28-16-8S). Similarly conjugated isotype control antibodies
were used in parallel. Cells were stained for 30 min with the rele-
vant antibodies, washed with PBS, fixed with 1% paraformalde-
hyde, and kept in the dark until use. 1,000 events were acquired
on a Becton Dickinson FACScan™.
Statistical Analysis. Student’s t test was used to determine the
significance of differences between controls and experimental
groups. Differences between experimental groups were consid-
ered significant for P values ,0.05.
Results
Mortality of S. typhimurium Infection in Wild-type, gp91
phox2/2, and iNOS2/2 Mice. gp91phox2/2 mice and con-
genic C57BL/6 wild-type control mice were infected in-
travenously with z600 CFU of S. typhimurium M525P.
All gp91phox2/2 mice were dead by day 4–5 of infection,
despite the modest inoculum, whereas no deaths were ob-
served among the C57BL/6 controls (Fig. 1 A). Thus,
NADPH phagocyte oxidase–dependent antimicrobial
mechanisms are required for host resistance in the early
stages of Salmonella infection in mice.
Groups of five to seven iNOS2/2 mice on the Salmo-
nella-susceptible C57BL/6 or Salmonella-resistant 129Sv
strain backgrounds were infected intravenously with 10-
fold decreasing doses ranging from 107–103 CFU of
moderately virulent S. typhimurium M525P or the highly
virulent S. typhimurium C5 strain, respectively. Congenic
wild-type C57BL/6 or 129Sv control mice were infected
in parallel experiments. Log10 LD50 values 1 mo after infec-
tion were found to be 3.35 6 0.06 in C57BL/6 iNOS2/2
mice and 4.29 6 0.19 in 129Sv iNOS2/2 mice, compared
with 5.42 6 0.22 and 5.28 6 0.07 in the respective control
groups. Thus, iNOS2/2 mice show increased susceptibility
to Salmonella, but can still survive infection with low bacte-
rial inocula over a 30-d observation period. This contrasts
with the gp91phox2/2 mice, for whom even a very modest
inoculum was rapidly lethal.
On the basis of the LD50 determinations, seven C57BL/6
iNOS2/2 mice and seven congenic wild-type controls were
infected intravenously with z105 CFU of S. typhimurium
M525P (Fig. 1 B). Similarly, nine 129Sv iNOS2/2 mice
and nine congenic wild-type mice were infected with
z105 CFU of S. typhimurium C5 (Fig. 1 C). All of the
C57BL/6  iNOS2/2 mice died within 18 d after inoculation
Figure 1. Survival of gp91phox2/2, iNOS2/2, and congenic wild-type
mice infected with S. typhimurium. (A) Eight gp91phox2/2 mice and eight
congenic C57BL/6 controls (Nramp1s, Salmonella susceptible) were in-
fected intravenously with z600 CFU of S. typhimurium M525P, a strain
of intermediate virulence. (B) Seven iNOS2/2mice and seven congenic
C57BL/6 controls (Nramp1s) were infected intravenously with z105
CFU of S. typhimurium M525P. (C) Nine iNOS2/2 mice and nine con-
genic 129Sv controls (Nramp1r, Salmonella resistant) were infected with
z105 CFU of the highly virulent S. typhimurium C5 strain. Results are
expressed as number of survivors at times after infection.240 Roles of phox and iNOS in Resistance to Salmonella
(with deaths beginning on day 13), whereas all of the
C57BL/6 wild-type mice survived the infection. Similarly,
eight out of nine (89%) iNOS2/2 mice in the 129Sv back-
ground died within 24 d after inoculation (with deaths
beginning on day 10), whereas only one of nine (11%)
wild-type control mice died throughout the course of the
experiment. Thus, iNOS2/2 mice infected with S. typhi-
murium show increased susceptibility to infection that leads
to death of the animals during the second and third week
of infection. No deaths were observed in parallel groups of
five uninfected iNOS2/2 or wild-type mice of either strain.
S. typhimurium Organism Burden After Infection of Wild-
type, gp91phox2/2, and iNOS2/2 Mice. Hepatic and splenic
bacterial burden was quantified in gp91phox2/2 and con-
genic C57BL/6 wild-type control mice after intravenous
infection with z600 CFU of S. typhimurium M525P. Bac-
terial counts by day 1 of infection were already significantly
higher in the NADPH phagocyte oxidase–deficient mice
compared with control animals, and were dramatically
higher by day 3 of infection (Fig. 2, A and B).
In parallel experiments, iNOS2/2 and congenic C57BL/6
wild-type mice were infected with 6.5 3 104 CFU of S. ty-
phimurium M525P, whereas iNOS2/2 and congenic 129Sv
wild-type controls were infected with 8.5 3 104 CFU of S.
typhimurium C5. Fig. 2, C and D shows that spleen and
liver bacterial counts were similar in C57BL/6- and
iNOS2/2- derivative mice during the first 5 d of infection,
despite the administration of higher inocula than those ad-
ministered to the gp91phox2/2 mice. However, by days 8
and 12, the counts in the livers of iNOS2/2 mice were sig-
nificantly higher than those of C57BL/6 control mice; by
day 21, the bacterial counts in both spleens and livers of
C57BL/6  iNOS2/2  mice were considerably higher in
comparison to controls. The course of infection and differ-
ences in bacterial counts between mutant and wild-type
mice were similar when a lower inoculum (6.5 3 103
CFU) was administered, except for lower absolute values
and an absence of deaths observed throughout the 30-d ex-
periment (data not shown). Fig. 2, E and F shows the
course of the infection with S. typhimurium C5 in 129Sv
and congenic iNOS2/2 mice. Bacterial counts in iNOS2/2
mutant and wild-type mice were similar until day 8 of the
infection. Thereafter, both spleen and liver counts were
significantly higher in the iNOS2/2 mice. Repeat experi-
ments gave similar results (data not shown).
Histopathology of S. typhimurium Infection in Wild-type,
gp91phox2/2, and iNOS2/2 Mice. Spleen weight was mon-
itored at specified times in the experiments described in
Fig. 2. The spleens of infected gp91phox2/2 increased in
size more rapidly (P , 0.01) than those of congenic
Figure 2. Bacterial counts in liver and spleen of
gp91phox2/2, iNOS2/2, and congenic wild-type mice
infected with S. typhimurium. (A and B) gp91phox2/2
mice and congenic C57BL/6 controls (Nramp1s) were
infected intravenously with z600 CFU of S. typhimu-
rium M525P, a wild-type strain of intermediate viru-
lence. All Salmonella-infected gp91phox2/2 mice were
dead by day four. (C and D) iNOS2/2 mice and con-
genic C57BL/6 controls (Nramp1s) were infected with
6.5 3 104 CFU of S. typhimurium M525P. (E and F)
iNOS2/2 mice and congenic 129Sv controls (Nramp1r)
were infected with 8.5 3 104 CFU of the highly viru-
lent wild-type S. typhimurium C5 strain. Spleen and
liver counts were determined at time points thereafter.
The results are expressed as Log10 viable count (mean 6
SD) obtained from groups of four mice per data point.241 Mastroeni et al.
C57BL/6 wild-type control mice (Fig. 3 A) after infection
with 600 CFU S. typhimurium M525P, in parallel with or-
ganism burden. As shown in Fig. 3 B, a similar increase in
spleen weight was observed during the first 8 d of the in-
fection in C57BL/6 iNOS2/2 mice and C57BL/6 mice in-
fected with 6.5 3 104 CFU of S. typhimurium M525P. The
mean spleen weight was slightly higher in C57BL/6 mice
than in C57BL/6 iNOS2/2on day 12 (P 5 0.02), but no
significant differences in spleen weight between iNOS2/2
mutant and wild-type mice were observed by day 21 of the
infection. A similar experiment performed with a lower
challenge dose (6.5 3 103 CFU per mouse) showed similar
spleen weights in iNOS2/2 mutant and C57BL/6 wild-
type mice at all time points (data not shown). Fig. 3 C
shows that significant (P 5 0.02) differences in spleen
weight between iNOS2/2 mice and congenic 129Sv wild-
type mice infected with 8.5 3 104 CFU of S. typhimurium
C5 appeared by day 8 after infection and persisted until at
least day 14.
Microscopic examination of livers of C57BL/6 and con-
genic gp91phox2/2 and iNOS2/2 mice revealed the early
formation of microabscesses rich in polymorphonuclear
neutrophils by day 3 of infection (Fig. 4, A–C), with more
extensive lesions noted in the gp91phox2/2 animals. On
days 8, 11, and 14, the focal lesions in the spleens and livers
of the infected C57BL/6 and iNOS2/2 mice consisted
mainly of mononuclear cells and were surrounded by nor-
mal tissue. This evolution of the inflammatory response
(10, 18) occurred similarly in both iNOS2/2 mice (Fig. 4,
D and F) and C57BL/6 mice (Fig. 4, E and G), showing no
iNOS dependence on the formation of mononuclear cell–
rich granulomas. In several iNOS2/2 mice it was visually
evident that the average size of focal granulomas was larger
than in congenic wild-type control mice. On day 21 of in-
fection, granulomatous lesions present in the livers and
spleens of iNOS2/2 mice in the C57BL/6 background
showed a variable degree of central necrosis (Fig. 4, H–K);
macroscopically visible abscesses were present in the livers
and occasionally in the spleens. The histological picture in
organs of wild-type 129Sv and congenic iNOS2/2 mice in-
fected with S. typhimurium C5 was similar to that described
in the C57BL/6 strain background, except for the absence
of central necrosis in the hepatic and splenic lesions.
The focal lesions in several liver sections were counted at
low-power magnification. As shown in Fig. 5, similar
numbers of inflammatory foci were present in the livers of
iNOS2/2 and congenic C57BL/6 mice on day 3 (predomi-
nantly neutrophils) and day 8 (predominantly mononuclear
cells) of infection, but the numbers of mononuclear cell–
rich lesions were significantly higher in C57BL/6 iNOS2/2
mice by days 12 and 21. Similar numbers of inflammatory
foci were found within the livers of iNOS2/2 and congenic
129Sv mice on day 3 of infection, but thereafter the num-
ber of lesions was significantly higher in the livers of the
iNOS2/2 mice. Thus, both iNOS2/2 mice and congenic
wild-type mice develop splenomegaly and form granulo-
mas in the spleen and liver during experimental salmonel-
losis.
Flow Cytometry of Splenocyte Populations in Salmonella-
infected Wild-type and iNOS2/2 Mice. Studies in mice treated
with iNOS inhibitors have suggested that iNOS might be
required for the recruitment of inflammatory cells to the
spleen (36). The percentages of CD11b1 cells and I-Ab1
CD11b1 cells were determined on days 3, 8, and 15 or 16
in the spleens of Salmonella-infected wild-type and iNOS2/2
mice in experiments parallel to those depicted in Fig. 2.
CD11b1 cells and I-Ab1CD11b1 cells were recruited to
infected spleens of iNOS2/2 mice and wild-type mice to a
similar degree and, at some time points, higher percentages
of inflammatory cells were present in the spleens of
iNOS2/2 mice compared with wild-type mice (Table I).
The percentages of CD41 T cells, CD81 T cells, CD251
cells, and B2201 cells in the spleens of wild-type and
Figure 3. Spleen weights of gp91phox2/2,  iNOS2/2, and congenic
wild-type mice infected with S. typhimurium. Mice were infected as de-
scribed in the legend to Fig. 2. Spleen weights were measured from (A)
infected gp91phox2/2 and congenic C57BL/6 mice, (B) iNOS2/2 and
congenic C57BL/6 mice, and (C) iNOS2/2 mice and congenic 129Sv
mice at designated time points. Results are expressed as mean spleen
weight  6  SD for four mice per data point.242 Roles of phox and iNOS in Resistance to Salmonella
iNOS2/2 mice were also comparable (not shown). The
results shown are representative of three individual experi-
ments that yielded similar results. Thus, the greater bacte-
rial burden observed in iNOS2/2 mice (Fig. 2, C–F)
cannot be attributed to an impairment in the infiltration of
inflammatory cells.
Serum IFN-g Levels in Salmonella-infected Wild-type and
iNOS2/2 Mice. Serum IFN-g was measured by ELISA in
the sera of six Salmonella-infected wild-type and six con-
genic iNOS2/2 mice at days 3, 7, 11, 16, and 21 of infec-
tion. No statistically significant differences (P . 0.05) in se-
rum IFN-g levels between iNOS2/2 and C57BL/6 wild-
Figure 4. (continues on facing page). Microscopic appearance of livers and spleens from gp91phox2/2, iNOS2/2, and congenic wild-type mice infected
with S. typhimurium. C57BL/6, gp91phox2/2, and iNOS2/2 were infected as described in the legend to Fig. 2. Hematoxylin and eosin–stained sections
were prepared from spleens and livers harvested at time points thereafter. Microabscesses were seen in the livers of (A) gp91phox2/2, (B) iNOS2/2, and
(C) wild-type animals on day 3. Granulomatous lesions were seen within the (D and E) spleens and (F and G) livers of (D and F) iNOS2/2 and (E and G)
wild-type C57BL/6 mice on day 8 (original magnification: 3200). The histopathology from days 11 and 14 closely resembled that observed on day 8.
Necrotic lesions were detected in the (H and I) livers and (J and K) spleens of iNOS2/2 mice on day 21. Approximate original magnifications: A–G,
3400; H, 360; I, 3200; and J–K, 3400.243 Mastroeni et al.
type mice after infection with S. typhimurium M525P were
detected on days 3, 7, and 11. Serum IFN-g levels at later
time points were statistically higher (P , 0.05) in iNOS2/2
mice (243 6 109 pg/ml on day 16; 430 6 44 pg/ml on day
21) than in C57BL/6 wild-type controls (82 6 62 pg/ml
on day 16; 75 6 9 pg/ml on day 21). Similarly, no differ-
ences in serum IFN-g levels between iNOS2/2 and con-
genic 129Sv wild-type mice infected with S. typhimurium
C5 were detected on days 3, 7, and 11, but IFN-g levels
on days 16 and 21 of infection were statistically higher (P ,
0.05) in the iNOS2/2 mice (500 6 99 pg/ml on day 16;
710 6 144 pg/ml on day 21) than in the 129Sv wild-type
controls (156 6 130 pg/ml on day 16; 200 6 49 pg/ml on
day 21). Thus, iNOS deficiency does not impair circulating
levels of IFN-g during Salmonella infection. Higher levels
of IFN-g at later time points are probably attributable to
increased organism burden, but may also reflect regulatory
effects of NO? on cytokine production.
Figure 4. (continued).244 Roles of phox and iNOS in Resistance to Salmonella
Discussion
Detailed study of the course of Salmonella infection in
gp91phox2/2 or iNOS2/2 mice has revealed major differ-
ences in the temporal contribution of the NADPH phago-
cyte oxidase and iNOS to host defense in salmonellosis.
Enhanced bacterial proliferation was observed in gp91
phox2/2 mice as early as day 1 after infection. In contrast,
iNOS2/2 mice effectively controlled bacterial growth in
the tissues during the first week of infection, but a lethal in-
crease in bacterial burden appeared later in the course of in-
fection.
Early killing of bacteria by resident phagocytes and acute
inflammatory cells during the first 24 h of infection appears
to be heavily dependent on the presence of an intact
NADPH phagocyte oxidase. These in vivo observations
correlate well with in vitro studies, suggesting a crucial role
for the oxidative burst in the rapid killing of ingested sal-
monellae by macrophages (28, 29, 35). The accelerated
replication of Salmonella in gp91phox2/2 mice that already
possess an innately susceptible Nramp1s (G169D) allele (40)
reveals a degree of independence between Nramp1 and ox-
idative burst–dependent host defenses, and shows that
Nramp1s mice still retain potent antimicrobial mechanisms
during the early phases of Salmonella infection. Indeed,
Nramp1 (Ity) is believed to limit bacterial growth rather
than enhance bacterial killing in vivo (41), whereas NADPH-
mediated oxidative mechanisms have been shown to medi-
ate killing of Salmonella by mononuclear cells (28, 29, 35).
iNOS expression in the tissues can be detected very early in
the course of a Salmonella infection (within 24 h) (32, 34;
our unpublished observations), raising the possibility of syn-
ergistic antimicrobial interactions between ROS and RNS,
as have been shown for Escherichia coli and S. typhimurium in
vitro (35, 42) and for sodC-deficient S. typhimurium in vivo
(24). However, such interactions are unlikely to be essen-
tial for the early killing of wild-type S. typhimurium in this
experimental model, because iNOS was dispensable for the
control of bacterial replication during the initial days of in-
fection.
The early bactericidal role of the NADPH phagocyte ox-
idase followed by a late essential bacteriostatic role of iNOS
mirrors our observations in elicited peritoneal phagocytes
(35). Although high levels of superoxide production during
initial phagocyte–pathogen interactions (with or without
the presence of smaller quantities of NO?) can generate a
variety of oxidant species, the subsequent predominant pro-
duction of NO? over time would be predicted to lead to a
progressive conversion to nitrosative chemistry (35, 43).
The tenuous stability of the activated NADPH phagocyte
oxidase complex (44), and perhaps even its direct inhibition
by nitrogen oxides (45), might contribute to the evolution
of the host response from ROS to RNS dependence. This
temporal progression of host defense may also be accounted
for by the greater reliance of acute inflammatory neutro-
phils and resident mononuclear cells on oxidative killing
mechanisms, succeeded by an influx of NO?-producing ac-
tivated macrophages. Although oxidative bacterial killing
by neutrophils is highly effective (46), organisms persisting
within mononuclear cells (10) may require slower iNOS-
dependent mechanisms for their eventual clearance.
Figure 5. Quantitation of focal hepatic lesions. Lesions were enumer-
ated from iNOS2/2 and congenic C57BL/6 mice infected with S. typhi-
murium M525P or iNOS2/2, and from congenic 129Sv mice infected
with S. typhimurium C5 as described in the legend to Fig. 2. Results are
shown as numbers of lesions in 15 low-power fields (mean 6 SD from
groups of four mice). *P # 0.01.
Table I. Flow Cytometry
CD11b1 I-Ab1CD11b1
Day 3
C57BL/6 12.45 5.0
C57BL/6 iNOS2/2 6.4 5.5
129 8.82 5.3
129 iNOS2/2 12.8 8.2
Day 8
C57BL/6 12.11 7.69
C57BL/6 iNOS2/2 15.1 7.3
129Sv 14.4 11.3
129Sv iNOS2/2 25.1 22.7
Days 15–16
C57BL/6 12.8 6.83
C57BL/6 iNOS2/2 21.3 9.05
129Sv 14.0 8.6
129Sv iNOS2/2 23.0 12.7
Percentages of CD11b1 and CD11b1I-Ab1 double positive cells in the
spleens of iNOS2/2 and congenic C57BL/6 mice infected with S.
typhimurium M525P, or iNOS2/2 and congenic 129Sv mice infected
with S. typhimurium C5. Mice were infected as described in the legend
to Fig. 2. Results are expressed as percentages of total cells. The data are
representative of three individual experiments that yielded similar results.245 Mastroeni et al.
In murine typhoid, iNOS is positively modulated by
IFN-g and TNF-a (12, 20); therefore, it could be hypoth-
esized that IFN-g and TNF-a mediate the suppression of
bacterial growth in the tissues of infected mice via NO?-
dependent mechanisms. However, there are important dis-
tinctions among the courses of infection in cytokine-defi-
cient, gp91phox2/2, and iNOS2/2 mice. In contrast to
iNOS2/2 mice, whole body X-irradiated mice, IFN-g2/2
mice, IFN-gR2/2 mice, TNFR552/2 mice, and mice
treated with anti–IFN-g or anti–TNF-a neutralizing anti-
bodies fail to suppress the early growth of salmonellae in
the reticuloendothelial system (11–13, 16; our unpublished
observations), and succumb within 7–8 d after challenge
with wild-type Salmonella under experimental conditions
similar to those used in this study (our unpublished obser-
vations). These observations indicate that IFN-g and TNF-a
do not exclusively enhance innate immunity via NOS acti-
vation. Later stages of Salmonella infection are controlled by
T cell–mediated immunity, and mouse strains lacking T
cells such as nu/nu mice, TcR-a/b2/2 mice, recombina-
tion activating gene (rag)12/2 mice, or scid mice fail to clear
Salmonella and succumb to infection despite initial suppres-
sion of early bacterial replication (13, 47; our unpublished
observations). At this time, we cannot exclude that some
degree of impairment in T cell responses to Salmonella
might occur in iNOS2/2 gene-targeted mutant mice, but
recent evidence from mouse models of Trypanosoma brucei
and Mycobacterium avium infection shows that iNOS-defi-
cient mice can mount effective T cell responses despite the
absence of high-output NO? production (48, 49).
Early histopathological examination of Salmonella-infected
mice revealed microabscesses containing neutrophils in all
strains, but lesions were most extensive with surrounding
necrosis in gp91phox2/2 animals. iNOS2/2 and wild-type
mice progressed to develop macrophage-rich granulomas
by day 8, but all gp91phox2/2 had succumbed to uncon-
trolled infection by this time point. We observed the de-
velopment of central necrosis in some granulomas during
later stages of infection in Nramp1s C57BL/6 iNOS2/2
mice but not in wild-type mice or Nramp1r 129Sv iNOS2/2
mice, possibly reflecting increased bacterial proliferation
leading to the death of the phagocytic and parenchymal
cells in the more susceptible mouse strain. Dysregulation of
cytokine production in the absence of RNS may also be
contributing to the development of necrosis (50, 51).
Results obtained after chemical iNOS inhibition during
Salmonella infection have suggested that impaired RNS pro-
duction can lead to a reduction of macrophage tissue infil-
tration and granuloma formation (32, 36). Nitrogen oxides
are known to play a role in the positive regulation of mac-
rophage inhibitory protein (MIP)-1a, a powerful chemoat-
tractant for macrophages (51), and have additional impor-
tant immunoregulatory properties (52). However, in this
study we found the morphology of granulomatous lesions
to be very similar in the tissues of iNOS2/2 and congenic
wild-type mice infected with S. typhimurium. In fact, focal
lesions and numbers of CD11b1 cells were even more nu-
merous in iNOS2/2 mice during late stages of infection
compared with wild-type mice. Increased granuloma for-
mation, which has also been noted in iNOS2/2 mice in-
fected with M. avium (53), may reflect inhibitory effects of
NO? on leukocyte recruitment (54). We have also shown
that the influx of inflammatory cells in the spleen as mea-
sured by flow cytometry, the development of splenome-
galy, the elevation of serum IFN-g levels, and the activation
of inflammatory cells as measured by I-Ab expression (12,
55) are not impaired in iNOS2/2 mice. Elevation of serum
IFN-g levels has also been described in iNOS2/2 mice in-
fected with T. brucei or Leishmania major (38, 56). The dis-
crepant findings in iNOS2/2 mice and animals administered
iNOS inhibitors may reflect NOS-independent actions of
inhibitors such as aminoguanidine (57), or residual or com-
pensatory mechanisms in the mice (58). Our results indicate
that NO? production plays an important antimicrobial ef-
fector role during salmonellosis. This conclusion is further
supported by observations in murine listeriosis, in which
iNOS inhibition exacerbates infection and bacterial burden
without apparent effects on hepatosplenic macrophage in-
flux and granuloma formation (59).
In conclusion, the course of experimental salmonellosis
in congenic mice lacking a functional NADPH phagocyte
oxidase or iNOS has revealed critical temporal differences
in the roles of these host immune effector mechanisms. The
early induction of the NADPH phagocyte oxidase results in
rapid bacterial killing, but this phase is rapidly succeeded by
a prolonged plateau phase with eventual bacterial clearance
dependent upon the induction of NO? production. This
coordinated response may maximize antimicrobial actions
of the innate immune system while limiting collateral tissue
injury from exposure to reactive oxidants.
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